These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22570519)

  • 41. Three-dimensional QSAR using the k-nearest neighbor method and its interpretation.
    Ajmani S; Jadhav K; Kulkarni SA
    J Chem Inf Model; 2006; 46(1):24-31. PubMed ID: 16426036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective QSAR-based prediction models with pharmacophore studies of oxadiazole-substituted α-isopropoxy phenylpropanoic acids on with dual activators of PPARα and PPARγ.
    Sharma MC
    Interdiscip Sci; 2014 Sep; ():. PubMed ID: 25183350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones.
    Roy K; Mandal AS
    J Enzyme Inhib Med Chem; 2008 Dec; 23(6):980-95. PubMed ID: 18608761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2D, 3D-QSAR and docking studies of 1,2,3-thiadiazole thioacetanilides analogues as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Jain SV; Ghate M; Bhadoriya KS; Bari SB; Chaudhari A; Borse JS
    Org Med Chem Lett; 2012 Jun; 2(1):22. PubMed ID: 22691718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigations of Structural Requirements for BRD4 Inhibitors through Ligand- and Structure-Based 3D QSAR Approaches.
    Tahir A; Alharthy RD; Naseem S; Mahmood N; Ahmed M; Shahzad K; Akhtar MN; Hameed A; Sadiq I; Nawaz H; Muddassar M
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29941841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies on [5,6]-Fused Bicyclic Scaffolds Derivatives as Potent Dual B-RafV600E/KDR Inhibitors Using Docking and 3D-QSAR Approaches.
    Liu HC; Tang SZ; Lu S; Ran T; Wang J; Zhang YM; Xu AY; Lu T; Chen YD
    Int J Mol Sci; 2015 Oct; 16(10):24451-74. PubMed ID: 26501259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Qsar study of some substituted 4-quinolinyl and 9-acridinyl hydrazones as antimalarial agents.
    Sahu NK; Sharma M; Mourya V; Kohli DV
    Acta Pol Pharm; 2012; 69(6):1153-65. PubMed ID: 23285677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 3D-QSAR and molecular docking studies on derivatives of MK-0457, GSK1070916 and SNS-314 as inhibitors against Aurora B kinase.
    Zhang B; Li Y; Zhang H; Ai C
    Int J Mol Sci; 2010 Nov; 11(11):4326-47. PubMed ID: 21151441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural insights into mode of actions of novel natural Mycobacterium protein tyrosine phosphatase B inhibitors.
    Dhanjal JK; Grover S; Sharma S; Singh A; Grover A
    BMC Genomics; 2014; 15 Suppl 1(Suppl 1):S3. PubMed ID: 24564493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved 3D-QSAR prediction by multiple-conformational alignment: A case study on PTP1B inhibitors.
    Zhang X; Mao J; Li W; Koike K; Wang J
    Comput Biol Chem; 2019 Dec; 83():107134. PubMed ID: 31629257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A 3D-QSAR study on a series of benzimidazole derivatives acting as hepatitis C virus inhibitors: application of kNN-molecular field analysis.
    Gupta SP; Samanta S; Patil VM
    Med Chem; 2010 Mar; 6(2):87-90. PubMed ID: 20218964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular dynamics and 3D-QSAR studies on indazole derivatives as HIF-1α inhibitors.
    Singh Y; Sanjay KS; Kumar P; Singh S; Thareja S
    J Biomol Struct Dyn; 2023 May; 41(8):3524-3541. PubMed ID: 35318905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 2D and 3D QSAR models for identifying diphenylpyridylethanamine based inhibitors against cholesteryl ester transfer protein.
    Chen M; Yang X; Lai X; Gao Y
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4487-95. PubMed ID: 26346366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modification of polychlorinated phenols and evaluation of their toxicity, biodegradation and bioconcentration using three-dimensional quantitative structure-activity relationship models.
    Tong L; Guo L; Lv X; Li Y
    J Mol Graph Model; 2017 Jan; 71():1-12. PubMed ID: 27825025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. QSAR Modeling, Molecular Docking and Molecular Dynamics Simulations Studies of Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Anticancer Agents.
    Abdizadeh R; Heidarian E; Hadizadeh F; Abdizadeh T
    Anticancer Agents Med Chem; 2021; 21(8):987-1018. PubMed ID: 32698753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved 3D-QSAR Prediction by Multiple Conformational Alignments and Molecular Docking Studies to Design and Discover HIV-I Protease Inhibitors.
    Patel PK; Bhatt HG
    Curr HIV Res; 2021; 19(2):154-171. PubMed ID: 33213349
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure Optimization of Neuraminidase Inhibitors as Potential Anti-Influenza (H1N1Inhibitors) Agents Using QSAR and Molecular Docking Studies.
    Inamdar P; Bhandari S; Sonawane B; Hole A; Jadhav C
    Iran J Pharm Res; 2014; 13(1):49-65. PubMed ID: 24734056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Computational investigation of imidazo[2,1-b]oxazole derivatives as potential mutant BRAF kinase inhibitors: 3D-QSAR, molecular docking, molecular dynamics simulation, and ADMETox studies.
    Boutalaka M; El Bahi S; Alaqarbeh M; El Alaouy MA; Koubi Y; Khatabi KE; Maghat H; Bouachrine M; Lakhlifi T
    J Biomol Struct Dyn; 2024 Jul; 42(10):5268-5287. PubMed ID: 37424193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    Med Chem; 2020; 16(7):903-927. PubMed ID: 31385775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.